Selank
Synthetic tuftsin analog studied in anxiolytic-like research.
Evidence Level
Emerging
Research Type
/ System Mapping
Where this compound appears in research pathways
Research-only note: This mapping is educational and does not represent a treatment protocol.
/ 01
Overview
Synthetic tuftsin analog studied in anxiolytic-like research.
/ 02
Mechanism of Action
Studied for GABAergic modulation and immune-neuroendocrine signaling.
/ 03
Research Applications
Stress response and anxiety models.
Studied for, research explores, preclinical models suggest, clinical studies have investigated.
/ 04
Studied Research Contexts
/ 05
Studied Research Dosing Ranges
Limited public data on dosing ranges across research models.
/ 06
Potential Adverse Effects Reported in Research
Adverse effect data is limited. Many compounds in this database lack human safety profiles.
/ 07
Mechanism Deep Dive
Selank is a synthetic peptide derived from tuftsin. Research describes anxiolytic-like activity in animal models, modulation of GABAergic signaling, and effects on stress-related and neuroimmune gene expression.
/ 08
Pathway Role
Operates within stress-response and GABAergic signaling pathways, with reported neuroimmune interaction.
/ 09
Biological Targets
/ 10
Research Applications
- Anxiety-like behavior animal models
- Stress and neuroimmune signaling research
- Cognitive endpoint preclinical studies
/ 11
Evidence Summary
Preclinical and limited regional clinical literature. Broader clinical validation is limited.
Evidence Level Rationale
Rated emerging due to limited internationally-replicated controlled clinical trials.
/ 12
Research Observation Timeline
Early Signal Window
Behavioral and gene expression changes within hours to days in animal models
Primary Study Window
Days to weeks in preclinical and regional clinical contexts
Endpoint Type
Behavioral and gene expression endpoints
Evidence Strength
Emerging
/ 13
Safety & Unknowns
Broad-population human safety profile is not extensively characterized.
/ 14
Research Limitations
Human outcome timing is not standardized across studies.
/ 15
References
References are being curated from peer-reviewed literature.
/ 07
Evidence Score
Overall Research Confidence
Emerging
Reflects breadth of mechanism, study type, and reproducibility across research literature.
/ 08
Related Peptides
Semax
Synthetic ACTH(4-10) analog studied in neurotrophic research.
Dihexa
Angiotensin IV analog studied in synaptogenesis research.
Cerebrolysin
Neuropeptide preparation studied in neuroregeneration research.
Appears in pathways
For research and educational purposes only.
Not medical advice. Not intended to diagnose, treat, cure, or prevent disease. Compounds discussed may not be approved for human use. Any dosing information shown describes ranges studied in research settings — never a recommendation.